Singapore markets closed

X4 Pharmaceuticals, Inc. (XFOR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.5894+0.0094 (+1.62%)
At close: 04:00PM EDT
0.5900 +0.00 (+0.10%)
After hours: 07:58PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-128,913
-101,167
-93,867
-88,696
-62,131
-
Depreciation & amortisation
354
419
513
499
351
-
Stock-based compensation
8,781
8,687
5,199
6,180
5,428
-
Change in working capital
1,818
344
5,736
-1,498
-4,063
-
Accounts payable
2,952
1,234
3,425
1,166
1,031
-
Other working capital
-103,707
-96,572
-77,205
-71,520
-60,180
-
Other non-cash items
2,243
2,279
2,436
2,486
998
-
Net cash provided by operating activities
-103,597
-96,512
-77,102
-70,905
-58,818
-
Cash flows from investing activities
Investments in property, plant and equipment
-110
-60
-103
-615
-1,362
-
Purchases of investments
-27,086
-16,823
0
0
-
-
Sales/maturities of investments
7,000
2,000
0
0
-
-
Other investing activities
-
-
-
-
-
27,406
Net cash used for investing activities
-20,196
-14,883
-103
-615
-1,362
-
Cash flows from financing activities
Debt repayment
-383
-2,064
-795
0
0
-
Common stock issued
-
59,999
122,631
75,985
-277
-
Common stock repurchased
443
0
0
-2,000
-277
-
Other financing activities
-
-631
-4,814
-
-278
-
Net cash used provided by (used for) financing activities
90,640
88,516
117,230
74,245
12,394
-
Net change in cash
-33,163
-22,780
39,920
2,406
-47,384
-
Cash at beginning of period
94,433
123,028
83,108
80,702
128,086
-
Cash at end of period
61,280
100,248
123,028
83,108
80,702
-
Free cash flow
Operating cash flow
-103,597
-96,512
-77,102
-70,905
-58,818
-
Capital expenditure
-110
-60
-103
-615
-1,362
-
Free cash flow
-103,707
-96,572
-77,205
-71,520
-60,180
-